Expression of Early Growth Response Gene-2 and Regulated Cytokines Correlates with Recovery from Guillain–Barré Syndrome | Zendy

Ernesto DoncelPérez | Zendy; Lourdes MateosHernández | Zendy; Eduardo Pareja | Zendy; Ángel García-Forcada | Zendy; Margarita Villar | Zendy; Raquel Tobes | Zendy; Francisco Romero Ganuza | Zendy; Virginia Viladel Sol | Zendy; Ricardo Ramos | Zendy; Isabel G. Fernández de Mera | Zendy; José de la Fuente | Zendy

Open Access

Expression of Early Growth Response Gene-2 and Regulated Cytokines Correlates with Recovery from Guillain–Barré Syndrome

Author(s) -

Ernesto DoncelPérez,

Lourdes MateosHernández,

Eduardo Pareja,

Ángel García-Forcada,

Margarita Villar,

Raquel Tobes,

Francisco Romero Ganuza,

Virginia Viladel Sol,

Ricardo Ramos,

Isabel G. Fernández de Mera,

José de la Fuente

Publication year - 2015

Publication title -

the journal of immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.737

H-Index - 372

eISSN - 1550-6606

pISSN - 0022-1767

DOI - 10.4049/jimmunol.1502100

Subject(s) - guillain barre syndrome , downregulation and upregulation , transcriptome , pathophysiology , medicine , disease , immune system , immunology , interleukin 6 , gene , peripheral neuropathy , gene expression , biology , cytokine , endocrinology , genetics , diabetes mellitus

Guillain-Barré syndrome (GBS) is an immune-mediated peripheral neuropathy. The goal of this research was the identification of biomarkers associated with recovery from GBS. In this study, we compared the transcriptome of PBMCs from a GBS patient and her healthy twin to discover possible correlates of disease progression and recovery. The study was then extended using GBS and spinal cord injury unrelated patients with similar medications and healthy individuals. The early growth response gene-2 (EGR2) was upregulated in GBS patients during disease recovery. The results provided evidence for the implication of EGR2 in GBS and suggested a role for EGR2 in the regulation of IL-17, IL-22, IL-28A, and TNF-β cytokines in GBS patients. These results identified biomarkers associated with GBS recovery and suggested that EGR2 overexpression has a pivotal role in the downregulation of cytokines implicated in the pathophysiology of this acute neuropathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research